Position in ACLX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$5,191,127
+$2,299,377 QoQ
Shares Held
45,211
+1.9% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. ACLX ranks #43 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ACLX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,191,127 | 45,211 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,891,750 | 44,352 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,304,338 | 52,428 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,630,969 | 55,140 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,182,065 | 63,751 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $4,593,961 | 59,903 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $4,908,550 | 58,778 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,342,858 | 60,570 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,686,289 | 53,002 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,854,642 | 51,435 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,842,509 | 51,352 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,594,564 | 50,429 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,433,096 | 46,514 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,331,799 | 42,989 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $711,814 | 37,923 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $263,931 | 14,598 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||